Navigation Links
Study Shows Vernakalant Hydrochloride is Effective in Conversion to Normal Heart Rhythm in Atrial Fibrillation Patients Following Cardiac Surgery
Date:11/7/2007

ORLANDO, Fla., Nov. 7 /PRNewswire/ -- Astellas Pharma US, Inc. today announced that the investigational agent vernakalant hydrochloride increased conversion to normal heart rhythm (sinus rhythm, or SR) in patients with atrial fibrillation (AF) following coronary artery bypass graft (CABG) or valvular surgeries. AF is a potentially serious condition characterized by an irregular heart rhythm and a high heart rate. The study results were presented at the annual meeting of the American Heart Association.

"Postoperative AF is common after cardiac surgery, occurring in up to 40% of patients and has a significant effect on both the intensive care unit and overall hospital length of stay," said Peter Kowey, MD, William Wikoff Smith Chair in Cardiovascular Research at the Main Line Health System. "This study shows that vernakalant may be an effective treatment option for converting AF to SR following CABG or valvular surgeries."

Study Results

The Atrial arrhythmia Conversion Trial or ACT II was a randomized, double-bind, placebo-controlled, parallel-group, multinational, multicenter study evaluating the efficacy and safety of vernakalant among patients who experienced AF or atrial flutter within 24 hours to 7 days after cardiac surgery.

Patients received vernakalant 3 mg/kg (n=107) or placebo (n=54) infused over 10 minutes. After 15 minutes, a second 10 minute infusion of vernakalant 2 mg/kg or placebo was given if AF or atrial flutter was present. The primary efficacy measure was the percentage of patients with treatment-induced conversion of AF/atrial flutter to SR for at least one minute within 90 minutes.

Patients demonstrating conversion within 90 minutes were categorized as responders. Other efficacy measures included time to conversion of all responders and percentage of AF patients demonstrating conversion to SR within 90 minutes for . one minute.

Following CABG or valvular surgery, a significantly higher percentage of pati
'/>"/>

SOURCE Astellas Pharma US, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., NEWYORK,Nov.25/PRNewswire/--Reportlinker.co...nitscatalogue: ,, PainManagement-GlobalTrends...n-Management---Global-Trends.html ,, Widesprea...entclinics,andtheadventofnewdrugshaveacceleratedth...eformsandreimbursementstructurecontinuetoshapedema...
(Date:11/25/2009)..., DELFT,TheNetherlandsandJOHANNESBURG,Novembe...visionandPyxisDiscoveryannouncedtoday,thattheyhave...ompanies,services. , Pyxis,sworldclasscomputa...pledwithiThemba,sservicedivisiontoprovidemedicinal...hroughPyxis,internationalclientnetwork.iThembaPha...
(Date:11/25/2009)..., MOUNTAINVIEW,Calif.,Nov.25/PRNewswire/-- C...icaldatafromtheCompany,sPROTECT-1(theProspectiveRa...)ofTraficet-EN(TM)(CCX282-B)inpatientswithmoderate...cywithafavorablesafetyandtolerabilityprofile.Thest...ctionofdiseaseseverityasdefinedasa70-pointdecrease...
Breaking Medicine Technology:Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Delaying Weight Loss Surgery May Leave Teens at Risk 58774 1Delaying Weight Loss Surgery May Leave Teens at Risk 58774 2Daily Dose of Vitamin D Helps Prevent Falls in Seniors 58770 1Daily Dose of Vitamin D Helps Prevent Falls in Seniors 58770 2Bionovo Announces Pricing of Securities Offering 58766 1Bionovo Announces Pricing of Securities Offering 58766 2Bionovo Announces Pricing of Securities Offering 58766 3
...idem tartrate sublingual lozenge) developed to be ...iddle of the night when patients awaken an...D, Calif., Oct. 1 Transcept Pharmaceuticals,Inc.,..., announced today,that it has submitted a New Drug...istration (FDA) for its lead product candidate, In...
...tics and genetic testing give women answers about ...ON, Ohio, Oct. 1 According to the U.S. Cancer,Sta... new cases of breast,cancer will be diagnosed in A...s are resulting in the earlier detection of the di...ted, breast cancer claimed the lives of,more than ...
Other Medicine Technology:Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 2Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 3Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 4Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 5Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 6Good Samaritan Hospital Launches High Risk Breast Cancer Program at Good Samaritan North Health Center 2Good Samaritan Hospital Launches High Risk Breast Cancer Program at Good Samaritan North Health Center 3Good Samaritan Hospital Launches High Risk Breast Cancer Program at Good Samaritan North Health Center 4
(Date:11/26/2009)... Dr. David Kim of the Live ...s surgery in Dallas , is one of a growing number o...social networking sites to connect with individual...ment to fight morbid obesity. Dr. Kim is utilizing...ormation about his practice with the community. ,...
(Date:11/26/2009)... Ennis & Ennis, P.A. is...ns for users of Yaz and Yasmin birth control pills...ulmonary Embolism, Stroke, Heart Attack or other r...oved. Women can call toll free at 1-800-856-6405 o...nislaw.com and fill out an online case evaluation...
(Date:11/25/2009)...,, EMERYVILLE,Calif.,Nov.25/PRNewswire-FirstCal...announcedthatthecompanywillhosttwoinvestoreventsin...2009-9:00a.m.CT/10:00a.m.ET ,, Principalinves...filzomibinrelapsedand/orrefractorymultiplemyeloma,...)AnnualMeetingandExpositioninNewOrleans,LA.Thetele...
(Date:11/25/2009)...,, LONGBEACH,Calif.,Nov.25/PRNewswire/--Thanksg...oundseniorsinthegreaterLongBeachareathankstoFaithI...IndependenceatHome(IAH),adivisionofSCANHealthPlan....ndredsofvolunteerstodeliverwarmThanksgivingmealsto...Bay,SouthLosAngelesandsurroundingcities. ,, "Ou...
(Date:11/25/2009)...,, SANFRANCISCO,Nov.25/PRNewswire/--TheBayAreaA...st Winter Spare the Air Alert forThu...uredfirelogsoranyothersolidfuel,bothindoorsandoutd...althyairqualitytomorrow,"saidJackBroadbent,executi...entstorespectthehealthoftheirneighborsandfellowcom...
Breaking Medicine News(10 mins):Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2
...he French agency Agence de Medecine,Preventive (AM... the Bill &,Melinda Gates Foundation to support th...ees in Africa and Asia. These Committees will help...w,vaccines. AMP will develop this project in partn...
...nded to Include Two ACRO Representatives, WASHING... Organizations (ACRO) and the Metrics Champion Con...ent of two representatives from,ACRO to the MCC Bo...elop biopharmaceutical performance standards, has,...
...th.com , Toronto Stock Exchange Symbol: CYT, MON...TSX: CYT), will,hold a conference call to discuss ....m. (Eastern Time) on Tuesday, August 5, 2008. The...issued at 7:00,a.m on Tuesday, August 5., DATE: ...
...lights , Some of the highlights that will be pre...am at Europe,s premier medical oncology meeting in... Identification of ,Achilles, heel, MicroRNa, SiR...ulating tumor cells, New targets for triple negati...
... In response to overwhelming industry int...nual Conference & Exhibition, VendorClear&trad...ve™ will now be available for purchase on li...ww.vendorclear.com/ [vendor access services] for ...
... Dyadem today announced that it has,signed a new d...f,production equipment for the pharmaceutical indu...ftware to help its customers minimize risk and,man...s for,pharmaceutical companies. Among its 400-stro...
Other Medicine News:Health News:French Agency Receives 10 Million Dollar Grant From the Bill & Melinda Gates Foundation to Support the Establishment of National Vaccine Advisory Committees in Africa and Asia 2Health News:French Agency Receives 10 Million Dollar Grant From the Bill & Melinda Gates Foundation to Support the Establishment of National Vaccine Advisory Committees in Africa and Asia 3Health News:MCC Names ACRO Leaders to Board of Directors 2Health News:CryoCath to Hold Third Quarter 2008 Conference Call and Webcast 2Health News:Get the latest on premier science in medical oncology 2Health News:Get the latest on premier science in medical oncology 3Health News:Get the latest on premier science in medical oncology 4Health News:VendorClear™ Announces Limited Release of New Products for Healthcare Facilities and Vendor Representatives 2Health News:Harro Hofliger Reduces Risk in Pharmaceutical Manufacturing Equipment with Dyadem 2Health News:Harro Hofliger Reduces Risk in Pharmaceutical Manufacturing Equipment with Dyadem 3
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
Medicine Products: